GlassScriptPhysician profile
Phillip Nelson Greer
NPI 1255610564
$2,036.10
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $162 · 2020: $101 · 2021: $266 · 2022: $99.56 · 2023: $112 · 2024: $1,296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $926 · Food and Beverage: $482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $926.04 |
| Food and Beverage | $481.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Patterson Companies, INC. | $900.00 | 2019-2024 | |
| Dentsply Sirona INC | $489.00 | 2024 | |
| Biohorizons Implant Systems INC. | $401.27 | 2019-2023 | Biohorizons |
| Align Technology, INC. | $100.58 | 2019-2022 | |
| Kerr Corporation | $35.41 | 2022-2023 | Maxcem Elite |
| Gc America INC. | $35.18 | 2024 | G-Aenial, Mi Paste |
| Nobel Biocare USA | $23.43 | 2023 | Nobelactive |
| Implant Direct Sybron International LLC | $19.50 | 2019 | |
| Envista Holdings Corporation | $14.11 | 2024 | Endodontics |
| American Medical & Dental Supplies,INC. | $10.00 | 2019 | |
| Ultradent Products INC | $7.62 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Greer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.